The Malignant
Hyperthermia Association of the United States (MHAUS)
is pleased to announce the availability of awards
in the amount of $2,000 and $1,500 to first-place
and second-place authors, respectively, of manuscripts
related to malignant hyperthermia (MH).
MH is an inherited muscle disorder that is “triggered”
by commonly used anesthetic agents and may lead to
death or disability. Early diagnosis and prompt treatment
are the keys to reducing MH-related morbidity and
mortality. MH may occur at any time during an anesthetic
whether in a hospital, ambulatory surgical center
or an office-based setting. A large variety of programs
have been developed by the scientific panel at MHAUS
in order to increase awareness of the syndrome and
its manifestations, including procedure manuals for
recognizing and treating MH applicable to the hospital
or the ambulatory surgical center, a continuing medical
education-accredited slide show and a variety of publications.
In order to promote awareness of MH and its various
manifestations and to encourage continued study of
the syndrome, George Massik, a founding member of
MHAUS, has graciously offered to support two writer
awards. The Daniel Massik Fund at The Foundation for
Jewish Philanthropies in Buffalo, New York, was established
by Mr. Massik in memory of his son who died from MH.
These awards will provide a stipend of $2,000 for
first place and $1,500 for second place to an anesthesiology
resident/fellow or an anesthesiologist who is within
five years of ending his/her training to attend the
ASA Annual Meeting or, in special circumstances, another
meeting of similar merit.
Award Details
The awards will be given to the primary author of
the best manuscript concerning MH. The format may
be a case report, literature review or original study.
Manuscript guidelines appear below:
| • The document should address a significant
issue related to the problem of MH. |
| • Those participating must currently
be a resident/ fellow in anesthesiology
or an anesthesiologist who is within five years
of ending his/her training. |
| • The paper must be a minimum of three
double-spaced, typed pages and a maximum of
10 pages. |
| • Deadline for receipt of the manuscript
in the MHAUS office is August 1, 2003. |
The award will be presented at the annual MHAUS Recognition
Reception at the ASA Annual Meeting in San Francisco,
California, in October 2003.
For further information regarding the application
process for this award, please contact the Malignant
Hyperthermia Association of the United States (MHAUS),
Attention: Dianne Daugherty, 11 East State Street,
P.O. Box 1069, Sherburne, NY 13460; send a fax to
(607) 674-7910 or e-mail at <info@mhaus.org>. |